The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 12, 2017
Filed:
Feb. 04, 2014
Applicants:
Rhizen Pharmaceuticals SA, La Chaux-de-Fonds, CH;
Incozen Therapeutics Pvt. Ltd., Hyderabad, IN;
Inventors:
Meyyappan Muthuppalaniappan, Hyderabad, IN;
Prashant K. Bhavar, Hyderabad, IN;
Srikant Viswanadha, Hyderabad, IN;
Swaroop K. Vakkalanka, Hyderabad, IN;
Gayatri S. Merikapudi, Hyderabad, IN;
Assignees:
INCOZEN THERAPEUTICS PVT. LTD., Hyderabad, IN;
RHIZEN PHARMACEUTICALS SA, La Chaux-de-Fonds, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 37/18 (2006.01); A01N 43/40 (2006.01); A01N 43/32 (2006.01); A01N 43/38 (2006.01); A61K 31/50 (2006.01); C07D 211/72 (2006.01); C07C 233/00 (2006.01); C12N 5/00 (2006.01); C07C 235/56 (2006.01); C07C 233/65 (2006.01); C07C 233/66 (2006.01); C07C 233/75 (2006.01); C07C 309/59 (2006.01); C07C 317/32 (2006.01); C07C 323/42 (2006.01); C07D 209/14 (2006.01); C07D 213/75 (2006.01); C07D 213/81 (2006.01); C07D 231/56 (2006.01); C07D 241/24 (2006.01); C07D 307/79 (2006.01); C07D 317/58 (2006.01); C07D 319/18 (2006.01); A61K 31/167 (2006.01); A61K 31/185 (2006.01); A61K 31/196 (2006.01); A61K 31/343 (2006.01); A61K 31/357 (2006.01); A61K 31/405 (2006.01); A61K 31/416 (2006.01); A61K 31/44 (2006.01); A61K 45/06 (2006.01); C07C 235/84 (2006.01); C07C 309/52 (2006.01);
U.S. Cl.
CPC ...
C07C 235/56 (2013.01); A61K 31/167 (2013.01); A61K 31/185 (2013.01); A61K 31/196 (2013.01); A61K 31/343 (2013.01); A61K 31/357 (2013.01); A61K 31/405 (2013.01); A61K 31/416 (2013.01); A61K 31/44 (2013.01); A61K 45/06 (2013.01); C07C 233/65 (2013.01); C07C 233/66 (2013.01); C07C 233/75 (2013.01); C07C 235/84 (2013.01); C07C 309/52 (2013.01); C07C 309/59 (2013.01); C07C 317/32 (2013.01); C07C 323/42 (2013.01); C07D 209/14 (2013.01); C07D 213/75 (2013.01); C07D 213/81 (2013.01); C07D 231/56 (2013.01); C07D 241/24 (2013.01); C07D 307/79 (2013.01); C07D 317/58 (2013.01); C07D 319/18 (2013.01); C07C 2101/02 (2013.01); C07C 2101/08 (2013.01);
Abstract
The present invention provides dihydroorotate dehydrogenase inhibitors, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of diseases or disorders wherein the inhibition of Dihydroorotate dehydrogenase is known to show beneficial effect.